STOCK TITAN

Minerva Neurosciences: Balyasny reports ~9.99% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Minerva Neurosciences, Inc. (NERV) ownership amendment reports that Balyasny Asset Management L.P., BAM GP LLC, Balyasny Asset Management Holdings LP, Dames GP LLC and Dmitry Balyasny may each be deemed to beneficially own the same 4,769,981 shares, or approximately 9.99% of the class. The amount consists of 4,257,000 shares and 512,981 shares issuable upon exercise of 13,500 warrants. The percentage is based on 47,747,559 shares outstanding as of August 4, 2026. The warrants are subject to a Beneficial Ownership Limitation that prevents exercise to the extent it would result in ownership above 9.99%. The reporting persons each report sole voting and dispositive power over the same position.

Beneficial ownership 4,769,981 shares Reported by each of the five reporting persons as the same position
Reported ownership percentage Approximately 9.99% Based on 47,747,559 shares outstanding as of August 4, 2026
Shares 4,257,000 shares Component of the reported amount
Shares issuable upon warrant exercise 512,981 shares Component of the reported amount
Warrants 13,500 warrants Subject to the Beneficial Ownership Limitation
Shares outstanding 47,747,559 shares As of August 4, 2026
Beneficial Ownership Limitation regulatory
"subject to the Beneficial Ownership Limitation"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
sole voting power regulatory
"sole power to vote or to direct the vote"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
sole dispositive power regulatory
"sole power to dispose or to direct the disposition"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
investment manager financial
"by virtue of its position as the investment manager of APHC"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Minerva Neurosciences (NERV) shares did the reporting persons report owning?

Each of the five reporting persons may be deemed to beneficially own 4,769,981 shares, approximately 9.99% of the class. The amount consists of 4,257,000 shares and 512,981 shares issuable upon exercise of 13,500 warrants; it is the same position reported by each, not separate holdings to add together.

What is the warrant exercise limit for the Minerva (NERV) reported stake?

The warrants are subject to a 9.99% Beneficial Ownership Limitation. It prevents the holder from exercising warrants to the extent the exercise would result in beneficial ownership above 9.99% of the outstanding shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





603380205

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



BALYASNY ASSET MANAGEMENT L.P.
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
BAM GP LLC
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
Balyasny Asset Management Holdings LP
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
Dames GP LLC
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
Dmitry Balyasny
Signature:/s/ Dmitry Balyasny
Name/Title:Dmitry Balyasny / Self
Date:11/16/2026

Keep reading